Natixis Advisors LLC Purchases 51,991 Shares of Colgate-Palmolive (NYSE:CL)

Natixis Advisors LLC boosted its position in Colgate-Palmolive (NYSE:CL) by 15.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 386,681 shares of the company’s stock after acquiring an additional 51,991 shares during the quarter. Natixis Advisors LLC’s holdings in Colgate-Palmolive were worth $40,141,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD boosted its position in Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after buying an additional 8,933,912 shares in the last quarter. Swedbank AB acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $286,370,000. Acadian Asset Management LLC boosted its position in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after buying an additional 2,955,442 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in Colgate-Palmolive by 40.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares in the last quarter. Finally, Ossiam boosted its position in Colgate-Palmolive by 368.4% in the first quarter. Ossiam now owns 1,563,768 shares of the company’s stock valued at $140,817,000 after buying an additional 1,229,891 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently commented on CL. Barclays lifted their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price for the company. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Morgan Stanley lifted their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Trading Up 2.3 %

NYSE:CL opened at $93.56 on Monday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a 50-day moving average of $99.31 and a 200-day moving average of $98.54. The company has a market cap of $76.44 billion, a PE ratio of 26.81, a PEG ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s payout ratio is presently 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.